How to manage lymphoid malignancies during novel 2019 coronavirus (CoVid-19) outbreak: a Brazilian task force recommendation
Hematol., Transfus. Cell Ther. (Impr.)
;
42(2): 103-110, Apr.-June 2020. ilus
Article
in English
| LILACS
| ID: biblio-1134022
ABSTRACT
ABSTRACT The novel Coronavirus (CoVid-19) outbreak is now consider a world pandemic, affecting more than 1,300,000 people worldwide. Cancer patients are in risk for severe disease, including a higher risk of intensive care unit (ICU) admission, need for invasive ventilation or death. Management of patients with lymphoid malignancies can be challenging during the outbreak, due to need of multiple hospital visits and admissions, immunosuppression and need for chemotherapy, radiotherapy and stem cell transplantation. In this article, we will focus on the practical management of patients with lymphoid malignancies during the COVID-19 pandemic, focusing on minimizing the risk for patients.
Full text:
Available
Index:
LILACS (Americas)
Main subject:
Leukemia, Lymphoid
/
Coronavirus
/
COVID-19
/
Lymphoma
Country/Region as subject:
South America
/
Brazil
Language:
English
Journal:
Hematol., Transfus. Cell Ther. (Impr.)
Journal subject:
Hematologia
/
TransfusÆo de Sangue
Year:
2020
Type:
Article
Affiliation country:
Brazil
Institution/Affiliation country:
AC Camargo Cancer Center/BR
/
Américas Oncologia/BR
/
CEON+BR
/
Centro de Cancer de Brasilia CETTRO/BR
/
Hospital Alemão Oswaldo Cruz/BR
/
Hospital Israelita Albert Einstein/BR
/
Hospital das Clínicas/BR
/
Hospital de Clínicas de Porto Alegre/BR
/
Instituto Nacional do Cancer - INCA/BR
/
Instituto do Cancer de São Paulo/BR
Similar
MEDLINE
...
LILACS
LIS